Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Assessment of the Role of 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Fungal Infections in Adults

F. Lamoth, H. Akan, D. Andes, M. Cruciani, O. Marchetti, L. Ostrosky-Zeichner, Z. Racil, CJ. Clancy

. 2021 ; 72 (Suppl 2) : S102-S108. [pub] 20210312

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21019052

Detection of 1,3-β-d-glucan (BDG) in serum has been evaluated for its inclusion as a mycological criterion of invasive fungal infections (IFI) according to EORTC and Mycoses Study Group (MSG) definitions. BDG testing may be useful for the diagnosis of both invasive aspergillosis and invasive candidiasis, when interpreted in conjunction with other clinical/radiological signs and microbiological markers of IFI. However, its performance and utility vary according to patient population (hematologic cancer patients, solid-organ transplant recipients, intensive care unit patients) and pretest likelihood of IFI. The objectives of this article are to provide a systematic review of the performance of BDG testing and to assess recommendations for its use and interpretation in different clinical settings.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019052
003      
CZ-PrNML
005      
20210830100627.0
007      
ta
008      
210728s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1093/cid/ciaa1943 $2 doi
035    __
$a (PubMed)33709130
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Lamoth, F $u Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland $u Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
245    10
$a Assessment of the Role of 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Fungal Infections in Adults / $c F. Lamoth, H. Akan, D. Andes, M. Cruciani, O. Marchetti, L. Ostrosky-Zeichner, Z. Racil, CJ. Clancy
520    9_
$a Detection of 1,3-β-d-glucan (BDG) in serum has been evaluated for its inclusion as a mycological criterion of invasive fungal infections (IFI) according to EORTC and Mycoses Study Group (MSG) definitions. BDG testing may be useful for the diagnosis of both invasive aspergillosis and invasive candidiasis, when interpreted in conjunction with other clinical/radiological signs and microbiological markers of IFI. However, its performance and utility vary according to patient population (hematologic cancer patients, solid-organ transplant recipients, intensive care unit patients) and pretest likelihood of IFI. The objectives of this article are to provide a systematic review of the performance of BDG testing and to assess recommendations for its use and interpretation in different clinical settings.
650    _2
$a dospělí $7 D000328
650    12
$a kandidóza invazivní $x diagnóza $7 D058365
650    _2
$a glukany $7 D005936
650    _2
$a lidé $7 D006801
650    12
$a invazivní mykotické infekce $x diagnóza $7 D000072742
650    _2
$a senzitivita a specificita $7 D012680
650    12
$a beta-glukany $7 D047071
655    _2
$a časopisecké články $7 D016428
700    1_
$a Akan, H $u Ankara University, Faculty of Medicine, Cebeci Campus, Hematology Clinical Research Unit, Ankara, Turkey
700    1_
$a Andes, D $u Department of Medicine and Microbiology and Immunology, University of Wisconsin, Madison, Wisconsin, USA
700    1_
$a Cruciani, M $u Infectious Diseases Unit, G. Fracastoro Hospital, San Bonifacio, Verona, Italy
700    1_
$a Marchetti, O $u Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland $u Department of Medicine, Ensemble Hospitalier de La Côte, Morges, Switzerland
700    1_
$a Ostrosky-Zeichner, L $u Division of Infectious Diseases, McGovern Medical School, Houston, Texas, USA
700    1_
$a Racil, Z $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic
700    1_
$a Clancy, C J $u Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
773    0_
$w MED00001133 $t Clinical infectious diseases : an official publication of the Infectious Diseases Society of America $x 1537-6591 $g Roč. 72, Suppl 2 (2021), s. S102-S108
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33709130 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830100627 $b ABA008
999    __
$a ok $b bmc $g 1689977 $s 1139498
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 72 $c Suppl 2 $d S102-S108 $e 20210312 $i 1537-6591 $m Clinical infectious diseases $n Clin Infect Dis $x MED00001133
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace